• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海南省吊罗地区恶性疟原虫对咯萘啶/磺胺多辛/乙胺嘧啶体内敏感性的5年监测

A 5-year surveillance of sensitivity in vivo of Plasmodium falciparum to pyronaridine/sulfadoxine/pyrimethamine in Diaoluo area, Hainan Province.

作者信息

Shao B R, Huang Z S, Shi X H, Meng F

机构信息

Institute of Parasitic Diseases, Chinese Academy of Preventive Medicine, WHO Collaborating Centre for Malaria, Shanghai, People's Republic of China.

出版信息

Southeast Asian J Trop Med Public Health. 1991 Mar;22(1):65-7.

PMID:1948261
Abstract

The surveillance of sensitivity of P. falciparum to pyronaridine/sulfadoxine/pyrimethamine has been carried out in Diaoluo area in Hainan Province where chloroquine-resistant falciparum malaria is endemic, covering an area of 406 square kilometers, with a population of 3745 in 1986. From 1986 all outpatients diagnosed as falciparum malaria were administered with PND/S/P as the only antimalarial. In vivo sensitivity of P. falciparum was measured in some patients who were treated in hospital. It was demonstrated that P. falciparum in the Diaoluo area has retained its sensitivity to a single oral dose of PND/S/P of 500/1,000/50 mg with 100% cure rate for at least 5 years.

摘要

在海南省吊罗地区开展了恶性疟原虫对咯萘啶/磺胺多辛/乙胺嘧啶敏感性的监测。该地区是耐氯喹恶性疟的流行区,面积406平方公里,1986年人口为3745人。自1986年起,所有诊断为恶性疟的门诊病人均使用咯萘啶/磺胺多辛/乙胺嘧啶作为唯一的抗疟药。对部分住院治疗的患者测定了恶性疟原虫的体内敏感性。结果表明,吊罗地区的恶性疟原虫对500/1000/50毫克的咯萘啶/磺胺多辛/乙胺嘧啶单剂量口服仍保持敏感性,治愈率达100%,至少持续了5年。

相似文献

1
A 5-year surveillance of sensitivity in vivo of Plasmodium falciparum to pyronaridine/sulfadoxine/pyrimethamine in Diaoluo area, Hainan Province.海南省吊罗地区恶性疟原虫对咯萘啶/磺胺多辛/乙胺嘧啶体内敏感性的5年监测
Southeast Asian J Trop Med Public Health. 1991 Mar;22(1):65-7.
2
[Studies on the sensitivity of Plasmodium falciparum to pyronaridine/sulfadoxine/pyrimethamine in vitro].恶性疟原虫对咯萘啶/磺胺多辛/乙胺嘧啶的体外敏感性研究
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2000;18(1):8-10.
3
[In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan].[云南南部恶性疟原虫对甲氟喹、奎宁、阿莫地喹、氯喹、咯萘啶及磺胺多辛/乙胺嘧啶的体外敏感性]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1994;12(2):140-2.
4
Effectiveness of amodiaquine, sulfadoxine-pyrimethamine, and combinations of these drugs for treating chloroquine-resistant falciparum malaria in Hainan Island, China.阿莫地喹、周效磺胺-乙胺嘧啶及其联合用药治疗中国海南岛氯喹耐药恶性疟的疗效
Bull World Health Organ. 1988;66(3):353-8.
5
Development of the new antimalarial drug pyronaridine: a review.
Biomed Environ Sci. 1992 Jun;5(2):149-60.
6
Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.奥里萨邦孙德尔加尔地区部落人群中恶性疟原虫对氯喹、阿莫地喹、奎宁、甲氟喹和磺胺多辛/乙胺嘧啶的敏感性状况
Indian J Malariol. 1992 Dec;29(4):211-8.
7
[Resistance of Plasmodium falciparum to 3 antimalarials in Turbo (Antioquia, Colombia), 1998].
Rev Panam Salud Publica. 2001 Jan;9(1):23-9. doi: 10.1590/s1020-49892001000100006.
8
In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.乌干达西部恶性疟原虫对氯喹、氨酚喹及磺胺多辛-乙胺嘧啶的体内敏感性
Trop Geogr Med. 1994;46(6):364-5.
9
[Chloroquine and fansidar resistance of Plasmodium falciparum now also in Ghana].[加纳现也出现恶性疟原虫对氯喹和 Fansidar 的耐药性]
Angew Parasitol. 1988 Nov;29(4):211-3.
10
Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay.乙胺嘧啶-磺胺多辛治疗孟买氯喹耐药恶性疟的疗效
J Assoc Physicians India. 1996 Oct;44(10):683-5.

引用本文的文献

1
Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.青蒿琥酯加咯萘啶治疗非复杂性恶性疟
Cochrane Database Syst Rev. 2014 Mar 4(3):CD006404. doi: 10.1002/14651858.CD006404.pub2.
2
Review of pyronaridine anti-malarial properties and product characteristics.吡喹酮抗疟特性和产品特征综述。
Malar J. 2012 Aug 9;11:270. doi: 10.1186/1475-2875-11-270.